246 related articles for article (PubMed ID: 18342967)
1. 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.
van Loon J; Offermann C; Bosmans G; Wanders R; Dekker A; Borger J; Oellers M; Dingemans AM; van Baardwijk A; Teule J; Snoep G; Hochstenbag M; Houben R; Lambin P; De Ruysscher D
Radiother Oncol; 2008 Apr; 87(1):49-54. PubMed ID: 18342967
[TBL] [Abstract][Full Text] [Related]
2. Analysis of incidental radiation dose to uninvolved mediastinal/supraclavicular lymph nodes in patients with limited-stage small cell lung cancer treated without elective nodal irradiation.
Ahmed I; DeMarco M; Stevens CW; Fulp WJ; Dilling TJ
Med Dosim; 2011; 36(4):440-7. PubMed ID: 21397488
[TBL] [Abstract][Full Text] [Related]
3. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
[TBL] [Abstract][Full Text] [Related]
4. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
Kolodziejczyk M; Kepka L; Dziuk M; Zawadzka A; Szalus N; Gizewska A; Bujko K
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1008-14. PubMed ID: 20656419
[TBL] [Abstract][Full Text] [Related]
5. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
Vanuytsel LJ; Vansteenkiste JF; Stroobants SG; De Leyn PR; De Wever W; Verbeken EK; Gatti GG; Huyskens DP; Kutcher GJ
Radiother Oncol; 2000 Jun; 55(3):317-24. PubMed ID: 10869746
[TBL] [Abstract][Full Text] [Related]
6. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
7. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].
Liu LP; Yu JM; Guo HB; Fu Z; Han AQ; Yang GR
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):453-6. PubMed ID: 17974282
[TBL] [Abstract][Full Text] [Related]
9. Role of computed tomography and [18F] fluorodeoxyglucose positron emission tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniques with and without elective nodal irradiation.
Ceresoli GL; Cattaneo GM; Castellone P; Rizzos G; Landoni C; Gregorc V; Calandrino R; Villa E; Messa C; Santoro A; Fazio F
Tumori; 2007; 93(1):88-96. PubMed ID: 17455878
[TBL] [Abstract][Full Text] [Related]
10. Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: How to use E(B)US-NA information in addition to PET-CT for delineation?
Peeters ST; Dooms C; Van Baardwijk A; Dingemans AM; Martinussen H; Vansteenkiste J; Decaluwé H; De Leyn P; Yserbyt J; Nackaerts K; De Wever W; Deroose CM; De Ruysscher D
Radiother Oncol; 2016 Aug; 120(2):273-8. PubMed ID: 27291644
[TBL] [Abstract][Full Text] [Related]
11. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
van Loon J; De Ruysscher D; Wanders R; Boersma L; Simons J; Oellers M; Dingemans AM; Hochstenbag M; Bootsma G; Geraedts W; Pitz C; Teule J; Rhami A; Thimister W; Snoep G; Dehing-Oberije C; Lambin P
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):329-36. PubMed ID: 19782478
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).
Erdi YE; Rosenzweig K; Erdi AK; Macapinlac HA; Hu YC; Braban LE; Humm JL; Squire OD; Chui CS; Larson SM; Yorke ED
Radiother Oncol; 2002 Jan; 62(1):51-60. PubMed ID: 11830312
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning.
Aristophanous M; Berbeco RI; Killoran JH; Yap JT; Sher DJ; Allen AM; Larson E; Chen AB
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e99-105. PubMed ID: 21377285
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
[TBL] [Abstract][Full Text] [Related]
15. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
17. Radiation treatment planning using positron emission and computed tomography for lung and pharyngeal cancers: a multiple-threshold method for [(18)F]fluoro-2-deoxyglucose activity.
Okubo M; Nishimura Y; Nakamatsu K; Okumura M; Shibata T; Kanamori S; Hanaoka K; Hosono M
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):350-6. PubMed ID: 20457349
[TBL] [Abstract][Full Text] [Related]
18. Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer.
Nestle U; Schaefer-Schuler A; Kremp S; Groeschel A; Hellwig D; Rübe C; Kirsch CM
Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):453-62. PubMed ID: 17058078
[TBL] [Abstract][Full Text] [Related]
19. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
[TBL] [Abstract][Full Text] [Related]
20. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
